During the past decade, Johns Hopkins University Pulmonary and Critical Care Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins University Pulmonary and Critical Care Medicine" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins University Pulmonary and Critical Care Medicine" are "Pulmonary Arterial Hypertension" (2 trials), "Combined Pulmonary Fibrosis and Emphysema" (1 trials), "Interstitial Lung Disease" (1 trials), "Pulmonary Hypertension" (1 trials) and "Systemic Sclerosis-Associated PAH" (1 trials). Many other conditions were trialed in "Johns Hopkins University Pulmonary and Critical Care Medicine" in a lesser frequency.

Most popular intervention types in "Johns Hopkins University Pulmonary and Critical Care Medicine" are "Drug" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ubenimex" (2 trials), "CMRI" (1 trials), "Inhaled Treprostinil" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins University Pulmonary and Critical Care Medicine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Johns Hopkins University Pulmonary and Critical Care Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Johns Hopkins University Pulmonary and Critical Care Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins University Pulmonary and Critical Care Medicine, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".